COMMUNIQUÉS West-GlobeNewswire

Adamis Provides Regulatory Update on Sublingual Tadalafil
27/02/2019
SAN DIEGO, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has received a Refusal to File letter from the United States Food and Drug Administration (FDA) [...]
ASLAN Pharmaceuticals to Partner With BioGenetics on Commercialisation of Varlitinib in South Korea
26/02/2019
SINGAPORE, Feb. 27, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, and BioGenetics [...]
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities
26/02/2019
MINNEAPOLIS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a proposed public offering of its common stock and warrants to purchase common [...]
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
26/02/2019
Phase 3 Geographic Atrophy Program Expected to Restart By or In Q2 2019 Phase 3 Trial of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria Expected to be Fully Enrolled by End of Q2 2019 Cash Position of $176.3 [...]
Supernus Announces Record Full Year 2018 Financial Results
26/02/2019
Fourth quarter 2018 total revenue of $115.9 million, a 31% increase over 2017, and fourth quarter 2018 net product sales of $113.5 million, a 32% increase over 2017. Fourth quarter 2018 operating earnings of $39.9 [...]
Veloxis to Host Conference Call Following Release of 2018 Annual Report
26/02/2019
Investor News no. 01/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 26 February 2019 Veloxis to Host Conference Call Following Release of 2018 Annual Report As previously announced, Veloxis Pharmaceuticals A/S ( [...]
Flexion Therapeutics to Present at the 40th Annual Raymond James Institutional Investors Conference
26/02/2019
BURLINGTON, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it will be presenting at the 40 th Annual Raymond James Institutional Investors Conference in Orlando, [...]
Harvard Bioscience Subsidiary Data Sciences International to Participate at SOT 2019 With Presentation and Exhibit
26/02/2019
Company To Sponsor Session on Novel Approaches for Respiratory Measurement, Showcase Portfolio of Instrumentation Products and Solutions and Present Data HOLLISTON, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences [...]
Atrion Reports Results for Fourth Quarter and Full Year 2018
26/02/2019
ALLEN, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2018 revenues were $34.9 million compared to $34.0 million in the same period of 2017, net [...]
BOAZ to Honour Human Potential with Handcrafted Art Installation at HempFest Edmonton
26/02/2019
The BOAZ team celebrates craft and growth as brand launches new identity EDMONTON, Alberta, Feb. 26, 2019 (GLOBE NEWSWIRE) -- BOAZ Pharmaceuticals Inc. (BOAZ) received its license for cultivation in June 2018, and the [...]
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results
26/02/2019
MINNEAPOLIS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Julie Bornstein and Tracey D. Brown Join Board of Directors of WW – the new Weight Watchers
26/02/2019
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- WW (NASDAQ: WTW) – the new Weight Watchers – today announced two board appointments: Julie Bornstein, Chief Executive Officer of a new venture-backed company she founded and [...]
Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis
26/02/2019
Clinical trial evaluating EQ001 for the treatment of refractory lupus nephritis to commence in 2H 2019 Ongoing EQ001 development programs in acute graft-versus-host disease and severe asthma remain on-track Company to [...]
Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results
26/02/2019
ANN ARBOR, Mich., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported [...]
VIVUS Reports Fourth Quarter 2018 Financial Results
26/02/2019
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a specialty pharmaceutical company committed to the development and [...]
Wright Medical Group N.V. Reports 2018 Fourth Quarter and Full-Year Financial Results and Provides 2019 Annual Guidance
26/02/2019
Fourth Quarter 2018 Net Sales, Including Cartiva, of $238 Million; Full-Year 2018 Net Sales, Including Cartiva, of $836 Million Cartiva Revenue of $9.5 Million From October 10, 2018 Closing Date Through Year-End Fourth [...]
Voyager Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
26/02/2019
Initiated RESTORE-1 Phase 2 trial for VY-AADC for Parkinson’s disease Began IND-enabling preclinical studies for ALS-SOD1 and Huntington’s disease programs Recently announced strategic collaborations with funding for [...]
WW Announces Fourth Quarter and Full Year 2018 Results
26/02/2019
Provides Full Year 2019 Guidance End of Period Subscribers up 22% year-over-year to 3.9 million Total Paid Weeks in Q4 2018 up 23% year-over-year; Total Paid Weeks in FY 2018 up 26% year-over-year Revenues in Q4 2018 of [...]
Dynavax Announces Fourth Quarter and Full Year 2018 Financial Results
26/02/2019
Fourth quarter 2018 HEPLISAV-B ® net product revenue of $3.9 million Phase Ib/2 safety data for inhaled DV281 will be presented at the AACR Annual Meeting SD-101 demonstrates consistent and meaningful clinical benefit [...]

Pages